Search Results - "CSUKA, O"

Analysis of microRNA expression in brush cytology specimens improves the diagnosis of pancreatobiliary cancer by Le, N., Fillinger, J., Szanyi, Sz, Wichmann, B., Nagy, Z.B., Ivády, G., Burai, M., Tarpay, Á., Pozsár, J., Pap, Á., Molnár, B., Csuka, O., Bak, M., Tulassay, Z., Szmola, R.

“…Malignant pancreatobiliary strictures are in many cases clinically indistinguishable and present a major problem to endoscopy specialists. Intraductal sampling…”
Get full text

MLH1 and MSH2 mutation screening in HNPCC families of Hungary – Two new MMR gene mutations by Tanyi, M, Olasz, J, Tanyi, J.L, Tóth, L, Antal-Szalmás, P, Ress, Z, Bubán, T, Palatka, K, András, C, Urbancsek, H, Garami, Z, Csuka, O, Damjanovich, L

“…Abstract Introduction Hereditary Non-Polyposis Colorectal Cancer is an inherited disease with deleterious germline mutations in the DNA mismatch repair genes…”
Get full text

In Vitro Search for Synergy Between Flavonoids and Epirubicin on Multidrug-resistant Cancer Cells by N. GYÉMANT, M. TANAKA, S. ANTUS, J. HOHMANN, O. CSUKA, L. MANDOKY, J. MOLNAR

“…The drug accumulation of a human multidrug resistance 1 (mdr1) gene-transfected mouse lymphoma cell line and a multidrug resistance protein (MRP)-expressing…”
Get full text

Continuous Administration of the Somatostatin Structural Derivative /TT-232/ by Subcutaneously Implanted Osmotic Pump Improves the Efficacy and Potency of Antitumor Therapy in Different Mouse and Human Tumor Models by TEJEDA, M, GAAL, D, HULLAN, L, CSUKA, O, SCHWAB, R, SZOKOLOCZI, O, KERI, G. Y

“…Background: The somatostatin structural derivative, TT-232, has a special 5-residue ring structure (D-Phe- Cys-Tyr-D-Trp-Lys-Cys -Thr-NH 2 ) and very different…”
Get full text

Difficulties in recognizing families with Hereditary Non-polyposis Colorectal Carcinoma. Presentation of 4 families with proven mutation by Tanyi, M, Olasz, J, Kámory, E, Csuka, O, Tanyi, J.L, Ress, Z, Damjanovich, L

“…Abstract Introduction Hereditary Non-polyposis Colorectal Carcinoma is the most frequent genetic disease leading to colon and other malignancies. Recognizing…”
Get full text

A Comparison of the Tumor Growth Inhibitory Effect of Intermittent and Continuous Administration of the Somatostatin Structural Derivative TT-232 in Various Human Tumor Models by TEJEDA, M, GAAL, D, HULLAN, L, CSUKA, O, SCHWAB, R, SZOKOLOCZI, O, KERI, G. Y

“…The tumor growth inhibitory efficacy of the somatostatin structural derivative TT-232 was studied using different routes of administration and treatment…”
Get full text

Corrigendum to: “Difficulties in recognizing families with Hereditary Non-polyposis Colorectal Carcinoma. Presentation of 4 families with proven mutation”, [Eur J Surg Oncol 34 (2008) 1322–1327] by Tanyi, M, Olasz, J, Kámory, E, Csuka, O, Tanyi, J.L, Ress, Z, Damjanovich, L

Get full text

A Tumor-Selective Somatostatin Analog (TT-232) with Strong in vitro and in vivo Antitumor Activity by Gy. Keri, Erchegyi, J., Horvath, A., Mezo, I., Idei, M., Vantus, T., Balogh, A., Zs. Vadasz, Gy. Bokonyi, Seprodi, J., Teplan, I., Csuka, O., Tejeda, M., Gaal, D., Zs. Szegedi, Szende, B., Roze, C., Kalthoff, H., Ullrich, A.

“…We report a series of new in vitro and in vivo data proving the selective antitumor activity of our somatostatin structural derivative, TT-232. In vitro, it…”
Get full text

Growth Inhibitory Effect of the Somatostatin Structural Derivative (TT-232) on Leukemia Models by TEJEDA, M, GAAL, D, CSUKA, O, KERI, G. Y

“…TT-232 is a structural derivative of the natural signal inhibitory peptide somatostatin, with selective antiproliferative and anti-inflammatory properties…”
Get full text

Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis by Fazekas, K, Csuka, O, Köves, I, Rásó, E, Tímár, J

“…The organ-specific metastasis characterizes several human cancers, including colon carcinoma, a disease that frequently involves metastases in the liver. The…”
Get full text

The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts by Tejeda, M, Gaal, D, Barna, K, Csuka, O, Kéri, Gy

“…A somatostatin structural derivative (TT-232) has been developed in our laboratory with strong antiproliferative effect but no GH- release inhibitory activity…”
Get more information

Antiproliferative effect of GNRH-III and GNRH-II peptide derivatives on MCF-7, T47-d and HT-29 cells by Szabo, I, Bosze, S, Kovacs, M, Vincze, B, Csuka, O, Hudecz, F, Mezo, G

Get full text

Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation by Erdélyi, Katalin, Ditrói, Tamás, Johansson, Henrik J., Czikora, Ágnes, Balog, Noémi, Silwal-Pandit, Laxmi, Ida, Tomoaki, Olasz, Judit, Hajdú, Dorottya, Mátrai, Zoltán, Csuka, Orsolya, Uchida, Koji, Tóvári, József, Engebraten, Olav, Akaike, Takaaki, Dale, Anne-Lise Børresen, Kásler, Miklós, Lehtiö, Janne, Nagy, Péter

“…Basal-like breast cancer (BLBC) is the most aggressive subtype of breast tumors with poor prognosis and limited molecular-targeted therapy options. We show…”
Get full text

Immunohistochemistry and reverse transcriptase polymerase chain reaction on sentinel lymph nodes can improve the accuracy of nodal staging in breast cancer patients by Péley, G, Tóth, J, Csuka, Sinkovics, I, Farkas, E, Köves, I

“…In this study the nodal staging sensitivity of sentinel lymph node biopsy (SLNB) with detailed pathological and molecular biological examination has been…”
Get more information

Novel somatostatin analogs with tyrosine kinase inhibitory and antitumor activity by Kéri, G, Mezö, I, Horváth, A, Vadász, Z, Balogh, A, Idei, M, Vántus, T, Teplán, I, Mák, M, Horváth, J

“…A series of new somatostatin analogs have been developed and tested for antitumor activity. Some analogs strongly inhibited tyrosine kinase activity of human…”
Get more information

Correlation of biochemical tumor markers with conventional pathological features in primary breast cancer by Péley, G, Bezzegh, A, Besznyák, I, Doleschall, Z, Csuka, O, Péter, I, Tóth, J, Számel, I, Schumann, B, Ottó, S

“…In this prospective study the correlation of pathological with biological prognostic factors and serum tumor markers has been investigated in 574 patients with…”
Get more information

Establishment and characterization of an EBNA-negative human lymphoma cell line (BHL-89) by Palyi, I, Fleischmann, T, Palyi, V, Daubner, D, Raposa, T, Paloczi, K, Benczur, M, Gergely, L, Csuka, O, Bak, M

“…National Institute of Oncology, Budapest, Hungary. BACKGROUND. The aim of the work was to establish human malignant lymphomas in culture, in order to study the…”
Get full text

Comparison of the tyrosine kinase activity with the proliferation rate in human colon solid tumors and tumor cell lines by Kéri, G, Balogh, A, Teplán, I, Csuka, O

“…The role of the tyrosine kinase signal transduction pathway was investigated in human colon solid tumors and colon tumor cell lines. A high level of tyrosine…”
Get more information

Progression of head and neck squamous cell cancer by Tímár, József, Csuka, Orsolya, Remenár, Eva, Répássy, Gábor, Kásler, Miklós

“…Squamous cell cancer in the head and neck region (HNSC) is unique concerning its progression since it remains locoregional for long time and visceral…”
Get full text

Novel antitumor peptide hormones and their effect on signal transduction by Kéri, G, Balogh, A, Horváth, A, Mezö, I, Vadász, Z, Bökönyi, G, Bajor, T, Vántus, T, Teplán, I, Horváth, J

“…A series of novel gonadotropin releasing hormone (GnRH) and Somatostatin analogs have been developed in our laboratory and were screened for antiproliferative…”
Get more information